bioRxivBioengineeringPreprint
Nanotopography reveals metabolites that maintain the immunosuppressive phenotype of mesenchymal stem cells
E. Ross, L.-A. Turner, A. Saeed, K. Burgess, G. Blackburn, P. Reynolds, J. Wells, J. Mountford, N. Gadegaard, M. Salmeron-Sanchez, R. Oreffo, M. Dalby
Abstract
Mesenchymal stem cells (MSCs) are multipotent stem cells that are immunosuppressive and thus of considerable therapeutic potential in transplant operations. However, MSCs rapidly differentiate once in culture, making their large-scale expansion for use in immunosuppressive therapies challenging. Although the differentiation mechanisms of MSCs have been extensively investigated using materials, little is known about how materials can modulate paracrine activities of MSCs. Here, we show for the first time that nanotopography can control the immunomodulatory capacity of MSCs through decreased intracellular tension increasing oxidative glycolysis. We also use the nanotopography to identify bioactive metabolites that modulate intracellular tension, growth and immunomodulatory phenotype of MSCs in standard culture. Our findings show a novel route to support large-scale expansion of functional MSCs for therapeutic purposes
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- research focus: metabolism & bioenergetics
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- UNDESRTANDING MESENCHYMAL STEM CELL IMMUNE POTENCY:A MORPHOLOMIC AND LIPIDOMIC PERSPECTIVE
P. PRIYADARSHANI, S. DeVeaux, … L. J. Mortensen·bioRxiv·May 25, 2022
- GRAPHENE OXIDE AS A NOVEL IMMUNOTHERAPY TOOL FOR THE MODULATION OF MYELOID-DERIVED SUPPRESSOR CELL ACTIVITY IN THE CONTEXT OF MULTIPLE SCLEROSIS
C. Camacho-Toledano, I. Machin-Diaz, … D. Clemente·bioRxiv·Mar 28, 2023
- Licensing Microgels Prolong the Immunomodulatory Phenotype of Mesenchymal Stromal Cells
M. Patrick, R. T. Annamalai·bioRxiv·Jul 5, 2022
- Sphingomyelinase Licensing of Mesenchymal Stromal Cells Alters Lipid and Protein Metabolites for Immunomodulation
S’Dravious A. DeVeaux, Daniel C. Shah, … Edward A. Botchwey·bioRxiv·Jul 17, 2025
- Mimicking physiological stiffness or oxygen levels in vitro reorganizes mesenchymal stem cells machinery toward a more naive phenotype
Inês Caramelo, Vera M. Mendes, … Bruno J. Manadas·bioRxiv·Jun 11, 2024
- Morphological Landscapes from High Content Imaging Identify Optimal Priming Strategies that Enhance MSC Immunosuppression
S. H. Andrews, M. W. Klinker, … R. A. Marklein·bioRxiv·Feb 23, 2021